EU Approves First Oral GLP-1 Treatment for Weight Management
The European Commission has approved Wegovy® pill as the EU's first oral…
Novo Nordisk Collaborates with Vivani Medical to Evaluate Long-Acting Semaglutide Implant
A new collaboration will evaluate a long-acting semaglutide implant for chronic weight…
UAE becomes second country globally to approve Wegovy pill for weight loss
The UAE has become the second country worldwide to approve the oral…
Abu Dhabi Expands Access to Innovative Daily Oral Obesity Treatment
Abu Dhabi has expanded access to an innovative daily oral obesity treatment…
Ozempic for Weight Loss: What You Need to Know
Ozempic is a medication originally developed for type 2 diabetes that is…
Abbott’s FreeStyle Libre® System & GLP-1 Meds Show Synergistic Impact in Type 2 Diabetes
ABBOTT PARK, Ill., March, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) today announced new data…
The Future of Cardiac Care: Defying the Threat of Cardiovascular Disease
Cardiovascular disease (CVD) is the number 1 killer worldwide and claims millions…
